Infectious agents and atherosclerotic vascular disease

QJM: An International Journal of Medicine

Volumn 89, Issue 10, 1996, Pages 727-735

  Cook, P J ^a   Lip, G Y H ^b  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; BLOOD RHEOLOGY; CAROTID ARTERY; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; INFECTION; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROLOGY; SEX DIFFERENCE; THROMBOGENESIS; TOOTH INFECTION; VIRUS INFECTION;

EID: 0029959611     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.10.727     Document Type: Review

References (127)

1. Smith EB. Development of the atheromatous lesion. Adv Exp Med Biol 1975; 57:254-60.
2. Woolf N. The distribution of fibrin within the aortic intima: an immunohistochemical study. Am J Pathol 1961; 39:521-32.
3. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314:488-500.
4. Mitchinson MJ. Macrophages and atherogenesis. Lancet 1987; ii:146-9.
5. Rosenfeld ME, Tsukada T, Gown AM, Ross R. Fatty streak initiation in Watanabe heritable hyperlipemic and comparable hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1987; 7:9-23.
6. Klurfeld DM. Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. Arch Pathol Lab Med 1985; 109:445-9.
7. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320:915-24.
8. Betzholtz C, Johnsson A, Aildin CH, et al. c-DNA and chromosomal localization of human platelet derived growth factor A-gene and its expression in tumor cell lines. Nature 1986; 320:695-9.
9. Davies MJ, Thomas AC. Thrombosis in acute coronary artery lesions in sudden ischaemic death. N Engl J Med 1984; 310:1137-40.
10. Hudson J, McCaughey WTE. Mural thrombosis and atherogenesis in coronary arteries and aorta. Atherosclerosis 1974; 19:543-53.
11. Smith EB. Fibrinogen and fibrin degradation products in relation to atherosclerosis. Clin Haematol 1986; 15:355.
12. Thompson WD, McGuigan CJ, Snyder C, Keen GA, Smith EB. Mitogenic activity in human atherosclerotic lesions. Atherosclerosis 1987; 66:85-93.
13. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973; 70:1753-9.
14. Burke JM, Ross R. Synthesis of connective tissue macromolecules by smooth muscle. Int Rev Connect Tiss Res 1979; 8:119-57.
15. McCullagh KE, Balian G. Collagen characterisation and cell transformation in human atherosclerosis. Nature 1975; 258:73-5.
16. Schwartz CJ, Ardlie NG, Carter RF, Paterson JG. Gross aortic sudanophilia and hemosiderin deposition. A study on infants, children and young adults. Arch Pathol 1967; 83:325-32.
17. Psaty BM, Koepsell TD, Manolio TA, Longstreth WT, Wagner EH, Wahl PW, Kronmal RA. Risk ratios and risk differences in estimating the effect of risk factors for cardiovascular disease in the elderly. J Clin Epidemiol 1990; 43:961-70.
18. Marmot MG. Lessons from the study of immigrant mortality. Lancet 1991; i:1455-8.
19. Weil J, Beevers DG. Cardiovascular disease in blacks, whites and Asians in Birmingham. In: Poulter N, Sever P, Thom S, eds. Cardiovascular Disease. Risk Factors and Intervention. Oxford, Radcliffe Medical Press, 1993:63-70.
20. Hypertension Detection and Follow-up Program Co-operative Group. Race, education and prevalence of hypertension. Am J Epidemiol 1977; 106:351-61.
21. Gill JS, Situnayake RD, Zezulka A, Buckley B, Beevers DG. Racial differences in coronary disease and diene conjugated lipids. Eur J Intern Med 1994; 5:9-14.
22. Garg R, Madans JH, Kleinman JC. Regional variation in ischemic heart disease. J Clin Epidemiol 1992; 45:149-56.
23. Hahn DL. Regional variation in ischemic heart disease: a possible missing risk factor? J Clin Epidemiol 1993; 46:668-9.
24. Cunningham MJ, Pasternak RC. The potential role of viruses in the pathogenesis of atherosclerosis. Circulation 1988; 77:964-6.
25. Petrie BL, Adam E, Melnick JL. Association of herpes virus/ cytomegalovirus infections with human atherosclerosis. Prog Med Virol 1988; 35:21-42.
26. Syryänen L. Is there a link between infection and infarction? Ann Clin Res 1988; 20:151-3.
27. Valtonen VV. Infection as a risk factor for infarction and atherosclerosis. Ann Med 1991; 23:539-43.
28. Pesonen E, Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 1981; 101:512-13.
29. Mattila KJ. Viral and bacterial infections in acute myocardial infarction. J Intern Med 1989; 225:293-6.
30. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53:481-2.
31. Burch GE, HarbJM, Hiramoto, Shewey L. Viral infection of the aorta of man associated with early atherosclerotic changes. Am Heart J 1973; 86:523-34.
32. Woods JD, Nimmo MJ, Mackay-Scollay EM. Acute transmural myocardial infarction associated with active Coxsackie virus B infection. Am Heart J 1975; 89:283-7.
33. Nicholls AC, Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet 1977; i:883-4.
34. Nikoskelainen J, Kalliomäki JL, Lapinleimu K, Stenvik M, Halonen PE. Coxsackie B virus antibodies in myocardial infarction. Acta Med Scand 1983; 214:29-32.
35. McDonald K, Rector TS, Braunlin EA, Kubo SH, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64:359-62.
36. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261:3561-6.
37. Lowry RW, Adam E, Hu C, et al. What are the implications of cardiac infection with cytomegalovirus before heart transplantation? J Heart Lung Transplant 1994; 13:122-8.
38. Melnick JL, Dreesman GR, Mecollum CH, Petrie GL, Burek J, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983; 2:644-7.
39. Yamashiroya HM, Ghosh L, Yang R, Robertson AL. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988; 130:71-9.
40. Min KW, Wickemeyer WJ, Chandram P, et al. Fatal cytomegalovirus infection and coronary arterial thromboses after heart transplantation: a case report. J Heart Transpl 1987; 6:100-5.
41. Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis. Eur Heart J 1993; 14(Suppl K):30-8.
42. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994; 42:170-4.
43. Sorlie PD, Adam E, Melnick SL, et al. Cytomegalovirus/ herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol 1994; 42:33-7.
44. Benditt EP, Barrett T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983; 80:6386-9.
45. Gyorkey F, Melnick JL, Guinn CA, Gyorkey P, DeBakey ME. Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta in arteriosclerotic patients, Exp Mol Pathol 1984; 40:328-31.
46. Minick CR, Fabricant CG, Fabricant J, Litrenta MM. Atheroarteriosclerosis induced by infection with a herpes virus. Am J Pathol 1979; 96:673-706.
47. Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, Grant AJ. Herpes simplex virus infection in human arterial cells. Implications in atherosclerosis. J Clin Invest 1987; 80:1317-21.
48. Jacob HS. Newly recognized causes of atherosclerosis: the role of micro-organisms. J Lab Clin Med 1994; 123:808-16.
49. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978; 48:335-40.
50. Calneil BW. Marek's disease and lymphoma. In: Rapp F, ed. Oncogenic herpes viruses. Boca Raton, FL, CRC Press, 1980:103-43.
51. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Herpesvirus-induced atherosclerosis in chickens. Fed Proc 1983; 42:2476-9.
52. Mattile KJ, Nieminen MS, Valtonen W, et al. Association between dental health and acute myocardial infarction. Br Med J 1989; 298:779-81.
53. Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis 1993; 103:205-11.
54. Blum A, Sclarovsky S, Rechavia E. 'Infective' myocardial infarction. Chest 1993; 103:1084-6.
55. Gerber DR, Friedman BC, Denny JT. 'Infective' myocardial infarction. Chest 1994; 105:1618-19.
56. Hicks RV, Melish ME. Kawasaki syndrome. Paed Clin N Am 1986; 33:1151-75.
57. Schulman ST (Ed.) Kawasaki disease. Proceedings of the Second International Kawasaki Disease Symposium. Prog Clin Bio Res 1987; 250.
58. Rowley AH, Gonzales-Crussi F, Schulman ST. Kawasaki syndrome. Rev infect Dis 1988; 10:1-15.
59. Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H. Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet 1992; 340:1127-9.
60. Marshall BJ. Campylobacter pyloridis and gastritis. J Infect Dis 1986; 153:650-6.
61. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori in and coronary heart disease. Lancet 1992; 339:896-7.
62. Cover TL, Blaser MJ. Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease, and gastric cancer. ASM News 1995; 61:21-6.
63. Wang JT, Lin JT, Sheu JC, Yang JC, Chen DS, Wang TH. Detection of Helicobacter pylori in gastric biopsy tissue by polymerase chain reaction, Eur J Clin Microbiol Infect Dis 1993; 12:367-1.
64. Barnes RJ, Uff JS, Dent JC, et al. Long-term follow up of patient with gastritis associated with Helicobacter pylori infection. Br J Gen Prac 1991; 41:286-8.
65. Sonnenberg A. Concordant occurrence of gastric and hypertensive diseases. Gastroenterology 1988; 95:42-8.
66. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori in and coronary heart disease. Br Heart J 1994; 71:437-9.
67. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain called TWAR from acute respiratory tract infections. N Engl J Med 1986; 315:161-8.
68. Cook PJ and Honeybourne D. Chlamydia pneumoniae. J Antimicrob Chemother 1994; 34:859-73.
69. Forsey T, Darouger S, Treharne JD, Jones BR, Herring AJ. Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of Chlamydia. J Infect, 1986; 12:145-52.
70. Saikku P, Leinonen M, Mattila K, et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; ii:983-6.
71. Saikku P. Chlamydia TWAR and its epidemiology. In: Proceedings of the First Conference of the European Society for Chlamydial Research. Stockholm, Almqvist & Wiksell International, 1988:7-10.
72. Saikku P, Leinonen M, Linnanmäki E, Mattila K, Nieminen MS, Valtonen V. Association of immune complexes containing chlamydial lipopolysaccharide with coronary heart disease. In: Bowie WR, Caldwell HD, Jones RP, et al., eds. Chlamydial Infections. Cambridge, Cambridge University Press, 1990:449-52.
73. Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol 1993; 31:2212-14.
74. Cook PJ, Lip GYH, Beevers DG, Wise R, Honeybourne D. Chlamydia pneumoniae and acute arterial thrombotic disease. Circulation 1995; 92:3148-9.
75. Thom DH, Wang SP, Stewart DK, Grayston JT. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. In: Bowie WR, Caldwell HD, Jones RP, et al., eds. Chlamydial Infections. Cambridge, Cambridge University Press, 1990:453-6.
76. Wang SP, Grayston JT. Micro-immunofluorescence serological studies with the TWAR organism. In: Oriel JD, Ridgway GL, Schachter J, Taylor-Robinson D, Ward M, eds. Chlamydial Infections. Cambridge, Cambridge University Press, 1986:329-32.
77. Van den Broucke JP, Kosenvuo M, Romanov K. Chlamydia TWAR and acute myocardial infarction (letter). Lancet 1989; i:158.
78. Andersen P, Pedersen OF, Bach B, Bonde GL. Serum antibodies and immunoglobulins in smokers and nonsmokers. Clin Exp Immunol 1982; 47:467-73.
79. Mili F, Flanders WD, Boring JR, Annest JL, Destefano F. The associations of race, cigarette smoking and smoking cessation to measures of the immune system in middleaged men. Clin Immunol Immunopath 1991; 59:187-200.
80. Blake GH, Abell T, Stanley W. Cigarette smoking and upper respiratory tract infection among recruits in basic combat training. Ann Int Med 1988; 109:198-202.
81. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscl Thromb 1992; 12:945-7.
82. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Int Med 1992; 116:273-8.
83. Hahn DL, Saikku P. Chlamydia, smoking and heart disease. Ann Int Med 1992; 117:71.
84. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992; 25(Suppl 1):27-34.
85. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82:158-61.
86. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167:841-9.
87. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications.J Clin Pathol 1996; 49:102-6.
88. Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol 1993; 31:2212-14.
89. Melnick SL, Shahar E, Folsom AR, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 1993; 95:499-504.
90. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92:3397-400.
91. Lopes-Virella MF, Virella G. Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin Immunol Immunopathol 1985; 37:377-86.
92. Beilke MA. Vascular endothelium in immunology and infectious disease. Rev Infect Dis 1989; 11:273-83.
93. Saikku P, Leinonen M, Linnanmäki E, Mattila K, Nieminen MS, Valtonen V. Association of immune complexes containing chlamydial lipopolysaccharide with coronary heart disease. In: Bowie WR, Caldwell HD, Jones RP, et al., eds. Chlamydial Infections. Cambridge, Cambridge University Press, 1990:49-452.
94. Parums D, Mitchinson MJ. Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaques. Atherosclerosis 1981; 38:211-16.
95. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6:131.
96. Versey JMB, Gabriel R. Soluble-complex formation after myocardial infarction. Lancet 1974; ii:493.
97. Füst G, Szondy E, Székely J, Nánai I, Gerö S. Studies on the occurrence of circulating immune complexes in vascular disease. Atherosclerosis 1978; 29:181-90.
98. Smith GW, McArthur CJ, Simpson IJ. Circulating immune complexes in myocardial infarction. J Clin Lab Immunol 1983; 12:197-9.
99. Smith KO, Gehle WD, Sanford BA. Evidence for chronic viral infections in human arteries. Proc Soc Exp Biol Med 1974; 147:357-60.
100. Beutler B, Cerami A. Cachectin: more than a tumour necrosis factor. N Engl J Med 1987; 316:379-85.
101. Beutler BA, Cerami A. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 1985; 135:3969-71.
102. Gamble JR, Harlan JM, Klebanoff SJ, et al. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumour necrosis factor. Proc Natl Acad Sci USA 1985; 82:8667-71.
103. Pober JS. Cytokine-mediated activation of vascular endothelium: physiology and pathology. Am J Pathol 1988; 133:426-33.
104. Bevilacqua MP, Pober JS, Majeau GR, et al. Recombinant tumour necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83:4533-7.
105. Tewari A, Buhles WC, Starnes HF. Preliminary report: effects of interleukin-1 in platelet counts. Lancet 1990; 936:712-14.
106. Ritchie DG, Levy BA, Adams MA, Fuller GM. Regulation of fibrinogen synthesis by plasma-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. Proc Nat Acad Sci USA 1982; 79:1530-4.
107. Sobotka PA, McMannis J, Fisher RI, Stein DG, Thomas JX. Effects of interleukin-2 on cardiac function in the isolated rat heart. J Clin Invest 1990; 86:845-50.
108. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkilä E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infection. Metabolism 1988; 37:859-65.
109. Pesonen E, Kaprio E, Rapola J, Soveri T, Oksanen H. Endothelial cell damage in piglet coronary artery after intravenous administration of E. coli endotoxin. Atherosclerosis 1981; 40:65-73.
110. Morel DW, DiCorleto PE, Chisolm GM. Modulation of endotoxin-induced endothelial cell toxicity by low density lipoprotein. Lab Invest 1986; 55:419-26.
111. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low-density lipoproteins: potential role in recruitment and retention of monocyte/ macrophages during atherogenesis. Proc Natl Acad Sci USA 1987; 84:2995-8.
112. Steinbrecher UP. Oxidation of human low-density lipoproteins results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 1987; 262:3603-8.
113. Estebauer H, Zollner H, Schaur RJ. Hydroxyalkenals: cytotoxic products of lipid peroxidation. ISI Atlas of Science. Biochemistry 1988; 1:311-17.
114. Fogelman AM, Schechter I, Seager J, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low-density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 1980; 77:2214.
115. Fowkes FGR, Lowe GDO, Housley E, et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease and risk of coronary heart disease. Lancet 1993; 342:84-6.
116. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118:956-63.
117. Lip GYH. Fibrinogen and cardiovascular disease. Q J Med 1995; 88:155-65.
118. Yarnell JWG, Baker IA, Sweetman PM, Bainton PJ, Elwood PC. Fibrinogen, viscosity and white blood cell count are major risk factors for ischaemic heart disease. Circulation 1991; 83:836-44.
119. Rasi V, Ikkala E, Valtonen V. Plasma β-thromboglobulin in severe infections. Thromb Res 1982; 26:267-74.
120. Reines H, Haluska P, Wise W, Cook J, Rambo W. Plasma thromboxane concentrations are raised in patients dying with septic shock. Lancet 1982; ii:174-5.
121. Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986; 41:8-15.
122. Richardson SGN, Matthews KB, Cruikshank JK, Geddes AM, Stuart J. Coagulation activity and hyperviscosity in infection. Br J Haematol 1979; 42:469-80.
123. Patel P, Carrington D, Strachan DP, et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994; 343:1634-5.
124. Lowe GDO. Blood rheology in arterial disease. Clin Sci 1986; 71:137-46.
125. Lip GYH, Beevers DGB. Abnormalities of rheology and coagulation in hypertension. J Hum Hypertens 1994; 8:693-702.
126. Goodman JL, Belongia EA, Holland EJ, et al. An outbreak of Herpes gladiatorum at a high school wrestling camp. N Engl J Med 1991; 325:906-11.
127. Hill TJ, Blyth WA, Harbouir DA. Trauma to the skin causes recurrence of Herpes simplex in the mouse. Virology 1978; 39:21-8.